Purpose To generate microplasmin (lPlm) using recombinant microplasminogen (lPlg) and recombinant tissue plasminogen activator (rt-PA) before intravitreous injection and to investigate the efficacy of lPlm in inducing posterior vitreous detachment (PVD). Methods Forty-eight female or male New Zealand white rabbits were randomized into three groups. Recombinant human lPlg was incubated with rt-PA with a 200:1 molar ratio at 371C for 40 min. The right eyes of groups 1, 2, and 3, were injected with 0.5, 1.0, and 1.5 U lPlm in 0.1 ml respectively, and 0.1 ml balanced salt solution (BSS) was injected into the left eye as controls. Scanning electron microscopy (SEM), gross specimen examination, B-ultrasonography and optical coherence tomography (OCT) were performed to detect vitreoretinal interface. Results Over eighty percent of recombinant human lPlg could be activated to active lPlm by rt-PA after 40 min incubation. Complete PVD was found at vitreous posterior pole of lPlm-treated eyes without morphological change of retina. Complete PVD of 25, 75, and 87.5% rabbit eyes was induced by 0.5, 1.0 and 1.5 U recombinant lPlm respectively on day 1. The remnants of vitreous cortex at the posterior pole were dependent on the concentration of lPlm. Among the four approaches for detecting PVD, SEM, gross specimen examination, and B-ultrasonography were more effective methods than OCT. Conclusion Intravitreous injection of 1.5 U lPlm can effectively induce complete PVD in rabbit eyes on day 1 without morphological change of retina.
Introduction
It is generally agreed that a complete posterior vitreous detachment (PVD) can greatly facilitate vitreoretinal surgery for macular hole (MH) repair and cystoid macular oedema (CME) in which a PVD has not developed spontaneously. The technique and instruments for vitreous surgery have developed greatly in recent years. However, surgical removal of the vitreous cortex carries the risk of retinal tear, retinal detachment, or retinal nerve fibre damage, 1, 2 especially in young patients. 3 Moreover, residual vitreous may cause proliferative vitreoretinopathy. 4 Enzymatic vitreolysis has potential as a simple and less invasive method than pars plana vitrectomy to relieve vitreoretinal traction by inducing PVD. Several enzymes, including chondroitinase, 5 hyaluronidase, 6, 7 and dispase, 8, 9 have been investigated for the induction of PVD. Among these, plasmin is one of the most promising enzymes because its activity decreases to an undetectable level within 24 h without excessive enzymatic effects, 10 and it is nontoxic to the retina. [11] [12] [13] However, isolation of autologous plasmin is a costly and time-consuming process. Furthermore, plasmin is produced with difficulty through gene recombinant technology because of its large molecular weight and is prone to degradation. Recombinant microplasminogen (mPlg) is a truncated protein produced by protein engineering technology and consists of the catalytic domain of native plasminogen. Upon activated to microplasmin (mPlm) by plasminogen activator, mPlg shares the same catalytic properties as human plasminogen.
14 mPlm is in phase 2 development as the first neuroprotective agent with thrombolytic potential for the treatment of ischaemic stroke. 15, 16 Recently, mPlg has been expressed with high yield in Pichia pastoris (about 400 mg/l culture broth). 17 Thus, mPlg will be a commercially available product, which allows immediate availability and does not require long and difficult preparation time to isolate the plasmin from autologous blood.
The aim of the present study is to (i) generate mPlm by incubating recombinant human mPlg with the recombinant human tissue plasminogen (rt-PA) activator and (2) investigate the safety and efficacy of mPlm in inducing PVD in rabbit eyes.
Materials and methods

Animals
Forty-eight female or male New Zealand white rabbits weighing 2-3 kg were randomized into three groups; each group consisted of 16 rabbits. The animals were treated in accordance with the ARVO statement for the use of animals in vision and ophthalmic research.
Activation of lPlg
Recombinant human mPlg was expressed in P. pastoris as described before. 17 rt-PA (Genentech, South San Francisco, CA, USA) was stored at -201C until administration, when these powders were reconstituted in sterile balanced salt solution (BSS) to the required concentrations.
To determine optimal activation time, mPlg at 10 mM (290 mg/ml) was incubated with tissue plasminogen activator at a 200:1 molar ratio. The incubation mixture consisted of 10 mM mPlg in 0.99 ml of BSS. The activation reaction was initiated by the addition of 10 ml of 5.0 mM (280 mg/ml) rt-PA at 371C. Samples of 50 ml were withdrawn at 10 min intervals, and the formation of mPlm was assayed by reduced sodium dodecyl sulphate gel electrophoretic (SDS-PAGE) analysis. Densitometric analysis was performed using the Image/J s 1.11 image processing and analysis program. The amidolytic activities of mPlm at different times were measured five times with the peptide substrate NH2-D-Val-Phe-Lyspnitroanilide (S-2251, Sigma, South San Francisco, MO, USA) as described before.
14 Plasmin (Sigma) was used as calibration and the mean activity values and standard deviations of five assays were used as the test results.
Injection of enzymes
The animals were anaesthetized with an intravenous pentobarbital sodium 10 mg/kg. Pupils were dilated with 0.5% tropicamide and 0.5% phenylephrine hydrochloride (Mydrin s -P, Santen, Osaka, Japan) or 1% atropine sulphate. Oxybuprocaine hydrochloride 0.4% (Benoxil s , Santen, Osaka, Japan) was applied for topical anaesthesia.
A prophylactic anterior chamber paracentesis was performed at the limbus to release approximately 0.1 ml of the aqueous to lower the intraocular pressure. Pars plana injection of 0.1 ml solution was performed 1 mm posterior to the limbus with a 30-gauge needle. The needle was maintained in place for 30 s to allow some pressure equilibration to prevent reflux of the solution. Groups 1, 2, and 3 were injected intravitreously with 0.5, 1.0, and 1.5 U of mPlm respectively. The same volume of BSS was injected into the left eye as control.
Clinical examination
Binocular indirect ophthalmoscopy and slit-lamp biomicroscopy with a þ 90 dioptre precorneal lens examinations were performed before and at periodic intervals after intravitreal injection of mPlm or BSS.
Eight rabbits were randomly assigned from each group on days 1 and 7 respectively for B-ultrasonography (BVI, Clermont-Ferrand, France) and optical coherence tomography (OCT). Then, rabbits were deeply anaesthetized and killed by intravenous injection of excessive sodium pentobarbital. After enucleation, the eyes were opened with a razor blade that penetrated the vitreous adjacent to the pars plana to ensure rapid penetration of the fixative. After 24 h fixation with 2.5% glutaraldehyde and 2% paraformaldehyde (0.1 M phosphate buffer salt and pH 7.4) at 41C, the eyes were bisected horizontally over the optic nerve into superior and inferior calottes in a circumferential manner. To avoid artificial mechanical PVD, the vitreous was dissected with a sharp razor. Care was taken to avoid damage to the adjacent retina. One of the calottes was used for gross specimen examination. The other was treated for histologic examination by scanning electron micrography.
Gross specimen examination
For gross specimen examination, the residual vitreous cortex on the surface of the posterior retina was assessed with the triamcinolone acetonide (TA) fine particle suspension (Bristol-Myers Squibb, Shanghai, China). Briefly, the calotte was rinsed three times with PBS and was laid horizontally opening upwards. TA fine particle Eye suspension (0.1 ml) was dropped uniformly onto the inner retinal surface. After incubation for 20 min at 251C, the calotte was rinsed three times with PBS and photographed using a digital colour video camera (DXC-390, Sony Electronics Inc., Park Ridge, NJ, USA).
Scanning electron microscopy
For scanning electron microscopy, a strip of tissue from the basement to the posterior pole was cut with a sharp razor. After 24 h of initial fixation, selected specimens were postfixed in osmium tetroxide 2% (Dalton's fixative), dehydrated in hexamethyldisilazane, dried to the critical point, sputter-coated in gold, and photographed using electron microscope (Hitachi S-520, Tokyo, Japan).
Electron photomicrographs were evaluated for the degree of vitreoretinal separation by determining whether a continuous or a discontinuous network of collagen fibrils covered the inner limiting membrane (ILM), whether single and sparse collagen fibrils were present on the ILM, or whether the ILM was devoid of any collagen fibrils. Figure 1 Time course of activation of recombinant human mPlg with rt-PA. (a) Reduced sodium dodecyl sulphate gel electrophoretic analysis showed that native mPlg was cleaved, and a major peptide of M r 27 000 was observed and it increased with time. At 40 min, about 80% of the mPlg had been cleaved as shown by densitometric analysis. (b) Amidolytic activity of the incubation solution also increased during the time studied. At 40 min, the mPlm amidolytic activity was higher than 80% of the same molar plasmin. Results are given as mean7SD (n ¼ 5).
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Histologic examination
For light microscopy, the tissue was transferred into phosphate buffer saline and kept at 41C overnight. After dehydration through a graded ethanol series and propylene oxide, it was embedded in paraffin.
Horizontal sections (5-mm-thick) were made and stained with hematoxylin and eosin.
Statistical analysis
Results were compared using analysis of cross- 
Results
Activation of lPlg by rt-PA Figure 1a shows reduced SDS-PAGE analysis of the time course of activation of recombinant human mPlg with rt-PA in BSS. Native mPlg was cleaved, and a major peptide of M r 27 000 was observed and it increased with time. At 40 min, about 80% of the mPlg was cleaved, as shown by densitometric analysis. There was also an increment of mPlm amidolytic activity during the time studied. At 40 min, the mPlm amidolytic activity was higher than 80% of the same molar plasmin (Figure 1b) . Thus, we decided to incubate these two reagents for 40 min.
Clinical examination
No abnormalities were found in all pre-injection eyes and control eyes. A slight temporary haze in the posterior vitreous had been observed in the test eyes 6 h after injection, but fundus remained visible. Twelve hours later, the vitreous became clear again. The lenses were clear with no dislocation. Retinal oedema, bleeding, or detachment was not found in any of the eyes.
In most mPlm-treated eyes, typical acoustic properties of complete PVD were observed. The B-ultrasonograph showed a very fluid, continuous, and undulating echogenic band with moderate backward movements in front of the retina (Figure 2a) . Eyes with partial PVD showed an echogenic band with focal attachment to the retina and were less mobile than complete PVD (Figure 2b ). There was cavity formation between vitreous and retina.
Optical coherence tomography could also determine the incomplete and complete PVD, in which the posterior hyaloid face did not move very far anteriorly from the retina. But at 7 days after injection, the edge of the PVD was more peripheral than the OCT could detect in all directions in partial eyes with complete PVD (Figures 3a  and b) .
Gross specimen examination
With TA fine particle suspension, the posterior hyaloid was clearly seen as a white-coloured gel on the whole inner retinal surface of all BSS-injected eyes (Figure 4a ). Scattered islands of posterior vitreous and thin posterior hyaloid membrane were left on the retina of partial PVD eyes. There was a smooth light reflex from ILM where cortical vitreous had detached from the retinal surface (Figure 4b ). In complete PVD eyes, smooth light reflex from ILM could be seen on the whole posterior retinal surface (Figure 4c ).
Electron microscopy
Examination by SEM showed that retinal inner surface of BSS-treated eyes was completely covered with a dense meshwork of collagen fibres (Figure 5a ). In SEM Figure 2 The B-ultrasonograph of vitreoretinal interface. (a) In complete PVD eyes, there was a continuous and undulating echogenic band with moderate backward movements in front of the retina, which was detached from the retina (arrow). (b) Eyes with partial PVD showed focal vitreous adhesions to the retina and less-mobile echogenic band than complete PVD (arrow). A cavity had been formed between vitreous and retina.
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photographs of incomplete PVD eyes, the internal limiting membrane was covered by remnants of cortical vitreous at the equator (Figure 5b ). There was a smooth and clean ILM in complete PVD eyes (Figure 5c ). A distinct correlation had been noted between the concentration of mPlm and degree of residual posterior vitreous cortical at 1 day after injection. Eyes that received 0.5 U mPlm had much more residual collagen fibrils than those that received 1.5 U mPlm (Table 1) .
Histologic examination
In light micrographs, 0.5, 1.0, and 1.5 U mPlm-treated eyes on either 1 or 7 days after injection showed similar retinal structure to that of BSS-treated eyes. The cellular layers of the retina were clearly demarcated, and the ILM was presented as a continuous membranous structure. There was no inflammatory reaction observed in posterior vitreous or retina.
Discussion
Previous investigators have introduced several methods to achieve sufficient plasmin concentrations in the vitreous. Injection of purified plasmin into the vitreous cavity, 10, 13, [18] [19] [20] [21] [22] or stimulation of plasmin production in the vitreous by t-PA injection, 23 cryocoagulation followed by t-PA injection, 24 or injection of purified human Degree of residual cortical vitreous of test eyes in groups 1-3 compared with those of control eyes.
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plasminogen and urokinase combination 25 were among the methods described.
Recombinant mPlg is the precursor of mPlm and is more easily preserved stably than mPlm and plasmin. For this reason, we considered it useful to incubate recombinant human mPlg with recombinant human rt-PA to generate mPlm before injection. Both reduced SDS-PAGE analysis and chromogenic substrate S-2251 confirmed more than 80% activation of mPlg by 0.5% molar ratio of rt-PA at 40 min. Our highest rt-PA dosage, 0.5mg/0.1 ml, was far below the values reported by Le Mer et al 23 and Hrach et al, 26 who observed clinical, electrophysiologic, and histological alterations in cat eyes receiving intravitreal rt-PA doses greater than or equal to 50 mg. Our histologic examinations confirmed the safety of very low dose of rt-PA. There was no difference in the retinal anatomy between mPlm-treated eyes and control eyes.
Similar to the results of Gandorfer et al, 27 our study demonstrated that mPlm alone produced cleavage at the vitreoretinal interface of rabbit eyes, and no additional surgical procedures were required to induce PVD. In controlled experiments on post mortem pig eyes, light microscopy and SEM verified that at sufficient concentrations and incubation times, plasmin-injected eyes developed PVD with the retinal surface smooth and free of cortical vitreous remnants. It is significant that enzymatic action alone was sufficient to induce PVD without the adjuvant gas bubble injection or cryotherapy necessitated in other studies. 20, 24 To assess the cleaving effect of mPlm at the vitreoretinal interface in vivo, we administered three different doses into the vitreous cavity of adult rabbits and observed on 1and 7 days after injection. There was a distinct correlation between the concentration of mPlm and the degree of residual posterior vitreous cortical on 1 day after injection. Intravitreous injection into rabbit eyes of 0.5 U mPlm (about 50% of the vitreous volume of the human eye), which is equivalent to 1.0 U mPlm into the human eye, could only induce complete PVD of 25% rabbit eyes on day 1. An amount of 1.5 U mPlm induced complete PVD of 75% rabbit eyes during the same time.
Comparison of three groups for days 1 and 7 did not show statistically significant deference in the degree of remnants of posterior vitreous hyaloid between days 1 and 7, suggesting consumption of the enzyme or an inhibitory mechanism against it within 24 h. This was consistent with the earlier studies on the plasmin. 19 The molecular weight of mPlm is 28 kDa, which is lower than the molecular weight of human plasmin (88 kDa). This should enable mPlm to penetrate the epiretinal tissue more effectively than plasmin. 27 On the other hand, this means a faster metabolism of mPlm than plasmin. As formal in vivo vitreous pharmacokinetic experiments have not been performed, the metabolism of mPlm in the vitreous cannot be determined at this time.
In addition, we used four approaches to detect complete PVD. According to the previous clinical finding, TA fine particle suspension improved the visibility of the hyaloid and the safety of the surgical procedures during pars plana vitrectomy and also inhibited the postoperative breakdown of the blood-ocular barrier. 28 Our results also showed that it succeeded in distinguishing complete PVD, incomplete PVD, and no PVD. The same efficacy was also seen in B-scan and SEM. Because the scanning depth of OCT was only 2 mm, OCT could not distinguish posterior hyaloid moving far from the retina in the complete PVD from posterior hyaloid attached to the retina in eyes with no PVD. Thus, according to our present study, SEM, B-Scan and gross examination were more effective approaches than OCT in detecting PVD. On the other hand, although SEM and gross examination are direct methods for PVD, there are also defects, because opening the eyecups, even with a sharp razor blade, can disrupt vitreous, particularly in rabbit eyes that have a very compliant scleral shell. In addition, crosslinking from fixation may alter the vitreous structure/vitreoretinal interface.
In conclusion, we described a new technique to produce mPlm by incubating two different recombinant compounds. mPlm is effective in inducing PVD and appears to be safe for the ocular ultrastructure. Compared with autologous plasmin, mPlm ensures the application of a pure substance at a defined dose. The rabbit vitreoretinal junction seems to be very strong, but is different from that in humans since it showed a constant ILM thickness and an absence of vitreal collagen fibrils inserting into the lamina densa of the ILM. 29 Further pharmacodynamic and toxicologic assessments in more appropriate animal models, such as the pig or monkey, are warranted before proceeding to clinical evaluation of this technique.
